Your browser doesn't support javascript.
loading
Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study.
Mills, Anthony M; Brunet, Laurence; Fusco, Jennifer S; Wohlfeiler, Michael B; Garris, Cindy P; Oglesby, Alan K; Mrus, Joseph M; Lackey, Philip C; Fusco, Gregory P.
Affiliation
  • Mills AM; Men's Health Foundation, Los Angeles, CA, USA.
  • Brunet L; Epividian, Durham, NC, USA. laurence.brunet@epividian.com.
  • Fusco JS; Epividian, Durham, NC, USA.
  • Wohlfeiler MB; Department of Medicine, AIDS Healthcare Foundation, Los Angeles, CA, USA.
  • Garris CP; ViiV Healthcare US, Research Triangle Park, NC, USA.
  • Oglesby AK; ViiV Healthcare US, Research Triangle Park, NC, USA.
  • Mrus JM; ViiV Healthcare US, Research Triangle Park, NC, USA.
  • Lackey PC; Atrium Healthcare, Charlotte, NC, USA.
  • Fusco GP; Epividian, Durham, NC, USA.
Infect Dis Ther ; 9(1): 41-52, 2020 Mar.
Article in En | MEDLINE | ID: mdl-31701370
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies Language: En Journal: Infect Dis Ther Year: 2020 Document type: Article Affiliation country: United States Country of publication: New Zealand
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies Language: En Journal: Infect Dis Ther Year: 2020 Document type: Article Affiliation country: United States Country of publication: New Zealand